Trends in Buprenorphine and Methadone Dispensing Among Medicare Advantage and Commercial Enrollees, 2019-2024
This study examined national trends in methadone and buprenorphine dispensing among Medicare Advantage and commercial enrollees with opioid use disorder from 2019 to 2024, characterizing differences by insurance type, age, and dual eligibility.